首页> Transplantation and cellular therapy> Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy.

Deepening Responses after Upfront Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction Therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mohammad,Ebraheem

第一单位： Division of Hematology, Mayo Clinic, Rochester, Minnesota.

作者： Mohammad,Ebraheem ^[1] ; Shaji K,Kumar ^[1] ; Angela,Dispenzieri ^[1] ; Dragan,Jevremovic ^[2] ; Francis K,Buadi ^[1] ; David,Dingli ^[1] ; Joselle,Cook ^[1] ; Martha Q,Lacy ^[1] ; Suzanne R,Hayman ^[1] ; Prashant,Kapoor ^[1] ; Nelson,Leung ^[3] ; Amie,Fonder ^[1] ; Miriam,Hobbs ^[1] ; Yi Lisa,Hwa ^[1] ; Eli,Muchtar ^[1] ; Rahma,Warsame ^[1] ; Taxiarchis V,Kourelis ^[1] ; Stephen,Russell ^[1] ; Moritz,Binder ^[1] ; Yi,Lin ^[1] ; Ronald S,Go ^[1] ; Mustaqeem A,Siddiqui ^[1] ; Robert A,Kyle ^[1] ; S Vincent,Rajkumar ^[1] ; Wilson I,Gonsalves ^[1] ; Morie A,Gertz ^[4]

作者单位： Division of Hematology, Mayo Clinic, Rochester, Minnesota. ^[1] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota. ^[2] Division of Hematology, Mayo Clinic, Rochester, Minnesota; Department of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota. ^[3] Division of Hematology, Mayo Clinic, Rochester, Minnesota. Electronic address: gertm@mayo.edu. ^[4]

关键词 Autologous stem cell transplantation MASS-FIX Minimal residual disease Multiple myeloma

医学主题词人类(Humans);移植, 自体(Transplantation, Autologous);多发性骨髓瘤(Multiple Myeloma);造血干细胞移植(Hematopoietic Stem Cell Transplantation);回顾性研究(Retrospective Studies);治疗结果(Treatment Outcome)

DOI 10.1016/j.jtct.2022.07.030

PMID 35940527

发布时间 2023-06-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交